注册 | 登录
点击这里给我发消息
所有产品
  • 所有产品
  • 一抗
  • 裂解液
>   首页   >   产品   >   一抗   >   其他   >   Anti-TNFSF5 / CD40L / CD154 Reference Antibody (Tegoprubart)   

Anti-TNFSF5 / CD40L / CD154 Reference Antibody (Tegoprubart)

     
  • 0 - Anti-TNFSF5 / CD40L / CD154 Reference Antibody (Tegoprubart) APR11222
    Anti-TNFSF5 / CD40L / CD154 Reference Antibody (Tegoprubart) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
  • 0 - Anti-TNFSF5 / CD40L / CD154 Reference Antibody (Tegoprubart) APR11222
    The purity of Anti-TNFSF5 / CD40L / CD154 Reference Antibody (Tegoprubart) is 99.2%, determined by SEC-HPLC.
  • 0 - Anti-TNFSF5 / CD40L / CD154 Reference Antibody (Tegoprubart) APR11222
    Immobilized SYMX14-Hu CD40L(116-261)-His at 2 µg/mL can bind Tegoprubart, EC50= 0.04316 µg/mL.
  • 产品详情
  • 实验流程
Product Information
Application
  • Applications Legend:
  • E=ELISA
  • WB=Western Blotting
  • IHC=Immunohistochemistry
  • IHC-P=Immunohistochemistry (Paraffin)
  • IP=Immunoprecipitation
  • IF=Immunofluorescence
  • IC=Immunochemistry
  • ICC=Immunocytochemistry
  • FC=Flow Cytometry
  • DB=Dot Blot
Functional assay, Kinetics (SPR), Kinetics (BLI), FACS, E, FTA
Primary Accession P29965
Reactivity Human
Clonality Monoclonal
Isotype IgG1-CS-CS-CS-PS
Calculated MW 29274 Da
Additional Information
Target/Specificity TNFSF5 / CD40L / CD154
Expression system CHO

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.

Protein Information
Name CD40LG
Synonyms CD40L, TNFSF5, TRAP
Function Cytokine that acts as a ligand to CD40/TNFRSF5 (PubMed:1280226, PubMed:31331973). Costimulates T-cell proliferation and cytokine production (PubMed:8617933). Its cross-linking on T-cells generates a costimulatory signal which enhances the production of IL4 and IL10 in conjunction with the TCR/CD3 ligation and CD28 costimulation (PubMed:8617933). Induces the activation of NF-kappa-B (PubMed:15067037, PubMed:31331973). Induces the activation of kinases MAPK8 and PAK2 in T-cells (PubMed:15067037). Induces tyrosine phosphorylation of isoform 3 of CD28 (PubMed:15067037). Mediates B-cell proliferation in the absence of co-stimulus as well as IgE production in the presence of IL4 (By similarity). Involved in immunoglobulin class switching (By similarity).
Cellular Location Cell membrane; Single-pass type II membrane protein. Cell surface
Tissue Location Specifically expressed on activated CD4+ T- lymphocytes
Research Areas
FeedBack

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。

如有疑问,联系:0512-88856768 tech-china@abcepta.com.


我要评价